Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin Lymphoma Refractory/ Relapsed

Explore clinical trials studying Non-Hodgkin Lymphoma Refractory/ Relapsed. Study availability and eligibility vary by location and protocol.

5 public trials 4 recruiting studies

Non-Hodgkin Lymphoma Refractory/ Relapsed trial results

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
Locations
  • City of Hope Duarte, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center - Bergen New York, United States
Conditions
Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of Arkansas Little Rock, Arkansas, United States
View all 38 locations

NCT07283822

Conditions
Cutaneous T-Cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +17 more
Locations
  • Columbia University Irving Medical Center New York, United States